--- title: "Preclinical Research CRO" canonical: "https://www.pharmalegacy.com/preclinical-research-cro/" lastmod: "2026-07-02T22:06:00+00:00" generator: "llm-mirrors/1.0.19" --- PharmaLegacy: Preclinical Contract Research Organization 1,500+ animal models. Non-human primates. 100+ indications. 30,000+ animal capacity. PharmaLegacy has the tools and capacity to confidently and quickly guide you to IND. Execute Preclinical Research Studies with Quality and Confidence Preclinical research is about more than just data. It’s about the future: a future where you have identified the most promising candidate that meets its endpoints and succeeds in the market. That future is only achievable if your data is a result of rigorously designed studies using the most relevant models and executed with care and precision. Your data will tell you a story, but is it the correct story? Being correct is everything, and we have spent decades developing our models to provide those correct answers. See why over 300 companies, including 18 of the top 20 pharmaceutical companies, trust PharmaLegacy for the answers to their preclinical drug development questions. PharmaLegacy can initiate most preclinical research studies in under 2 weeks! Contact PharmaLegacy today. Our Animal Models and Services Cover: Infectious Diseases Oncology & Immuno-Oncology Inflammation, Immunity & Autoimmunity Metabolic Diseases Hepatic & Renal Diseases Cardiovascular Diseases Pulmonology / Lung Diseases Bone Diseases / Orthopedics Ophthalmic Diseases Otology Pain & Migraine Central Nervous System Disorders Bacterial Infections Viral Infections Fungal Infections Central Nervous System Infections Respiratory Infections Sensory System Infections Gastrointestinal Infections Cardiovascular Infections Urogenital Infections Skin / Mucosa / Muscle Infections Systemic Infections MORE INFO ON INFECTIOUS DISEASE MODELS Humanized Mouse Models Syngeneic Mouse Models Xenograft Mouse Models Nude Rat Models Ex Vivo Tumor Studies Bone Metastasis Human Cancer Cell Panels Antibody-Drug Conjugate Characterization & Evaluation MORE INFO ON ONCOLOGY & IMMUNO-ONCOLOGY STUDIES Arthritis Allergy & Hypersensitivity Colitis Neuroinflammation Uveitis / Conjunctivitis Pneumonitis / Acute Lung Inflammation Psoriasis Systemic Lupus Erythematosus Graft-Versus-Host Disease Sepsis General Inflammation MORE INFO ON IMMUNE / AUTOIMMUNE MODELS Diabetes Mellitus Obesity and Hyperlipidemia Hyperuricemia MORE INFO ON METABOLIC DISEASE MODELS Liver Fibrosis & Cirrhosis NAFLD / NASH Immune-Response Related Hepatitis Chronic Kidney Disease Acute Kidney Disease Cardio-Renal Syndrome MORE INFO ON HEPATIC & RENAL DISEASE MODELS Heart Failure Cardio-Renal Syndrome Stroke Thrombosis Hemorrhage / Hemostasis MORE INFO ON CARDIOVASCULAR DISEASE MODELS Pulmonary Fibrosis Asthma Pneumonitis / Acute Lung Inflammation Cough MORE INFO ON PULMONOLOGY / LUNG DISEASE MODELS Osteoporosis Models Osteoarthritis Models Bone Defect & Bone Repair Studies Bone Safety Studies Cartilage Tissue Repair Ligament / Tendon Repair Studies Osteomyelitis Models MORE INFO ON BONE DISEASE / ORTHOPEDICS STUDIES Dry AMD / Geographic Atrophy Wet AMD Diabetic Retinopathy / Edema Retinal Vein Occlusion Retinopathy of Prematurity Subretinal Fibrosis Proliferative Vitreoretinopathy (PVR) Thyroid Eye Disease Glaucoma / Neuroprotection Uveitis Conjunctivitis Dry Eye Corneal Diseases Pterygium Myopia Presbyopia Cataracts Inherited Eye Disease MORE INFO ON OPHTHALMIC DISEASE MODELS in vitro Otology Studies Hearing Impairment Models Ototoxicity Studies MORE INFO ON OTOLOGY STUDIES Acute Inflammatory Pain Models Chronic Inflammatory Pain Models Acute Nociception Pain Models Visceral Pain Models Migraine Models MORE INFO ON PAIN & MIGRAINE MODELS Neurodegenerative Diseases Alzheimer’s Disease Parkinson’s Disease Amyotrophic Lateral Sclerosis (ALS) Huntington’s Disease Spinal Muscular Atrophy Rett Syndrome Aging Neuropsychiatric Diseases Depression Anxiety / Fear Schizophrenia Addiction Seizure Sleeping Disorder Contact PharmaLegacy Today! ✕ Let PharmaLegacy provide the answers you need. The Experience to Deliver PharmaLegacy’s preclinical research services have supported over 600 IND applications. We have been trusted with critical studies by 18 of the top 20 pharmaceutical companies. Combined with the extensive experience of our scientific staff – over 15 years on average – PharmaLegacy empowers the advancement of your preclinical pipelines with clarity and confidence. The Tools to Succeed With 380,000 square feet of facility space, the latest in analytical equipment, and over 1,500 models spanning over 100 indications, PharmaLegacy is equipped to obtain the rich, high-fidelity data you need to make critical pipeline decisions and draft strong IND submissions. We maintain surplus availability of most models so we can start most studies nearly immediately. We can even initiate NHP studies in as little as two weeks. Uncompromising Quality and Compliance World-class preclinical research demands rigorous, verifiable quality. We ensure data integrity and regulatory confidence through strict adherence to international standards. Our quality framework includes: AAALAC-accredited facilities Adherence to international GLP and QA best practices FDA 21 CFR Part 11 compliance for electronic records PRECLINICAL RESEARCH DONE PROPERLY Choosing a preclinical CRO is a critical decision. At PharmaLegacy, we deliver the world-class execution and data integrity you expect, with the speed and efficiency you need to respect your budget and timelines. Find out why clients who work with PharmaLegacy stay with PharmaLegacy. Tell us about your project, and let’s build a plan to move your preclinical pipelines forward. Top Pharmaceutical Companies Trust PharmaLegacy for their Preclinical Drug Development “The study they delivered on a very reasonable budget was top notch […] The model was executed flawlessly.” See why a top-20 pharmaceutical company trusts PharmaLegacy for its preclinical immuno-oncology trials. download the case study ✕ Download the Case Study